No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis
- 1 January 2007
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 97 (01), 32-37
- https://doi.org/10.1160/th06-09-0486
Abstract
Schattauer Verlag ist ein renommierter Herausgeber von Fachbüchern, Fachzeitschriften und Fachsoftware. Besuchen Sie unser Internetangebot mit Onlinezugang zu unseren ZeitschriftenartikelnThis publication has 38 references indexed in Scilit:
- Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studiesJournal of Thrombosis and Haemostasis, 2005
- Plasma homocysteine concentration is not associated with activated protein C resistance in patients investigated for hypercoagulabilityThrombosis and Haemostasis, 2004
- Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal investigation of thromboembolism etiology (LITE)American Journal of Hematology, 2003
- Common C677T Polymorphism of the Methylenetetrahydrofolate Reductase Gene and the Risk of Venous Thromboembolism: Meta-Analysis of 31 StudiesPathophysiology of Haemostasis and Thrombosis, 2002
- Homocysteine Inhibits Inactivation of Factor Va by Activated Protein COnline Journal of Public Health Informatics, 2001
- Single and Combined Prothrombotic Factors in Patients With Idiopathic Venous ThromboembolismArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosisThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Confidence Interval Estimation of InteractionEpidemiology, 1992